A document by the COVAX Facility organizers has revealed that Zimbabwe will likely receive about 1.1 million doses of the AstraZeneca/Oxford COVID-19 vaccine before 2021’s first-quarter runs dry.
The document seen by the publication states that the following countries will receive the following doses initially:
- Zimbabwe will receive 1,151 million doses
- South Africa 2,916 million doses
- Zambia 1,428 million doses
- Mozambique 2,424 million doses
- Malawi 1,476 million doses
- Nigeria 16 million doses.
A report seen by the publication stated that the figures mentioned above are subject to change:
This indicative distribution is intended to provide interim guidance to facility participants offering a planning scenario to enable preparations for the final allocation of the number of doses each participant will receive in the first rounds of vaccine distribution,” the Covax Facility said in a statement yesterday.
It is, therefore, non-binding and may be subject to change, due to the caveats outlined below. Nevertheless, Covax partners believe the publication of this information, which has now been shared with all economies participating in the Covax Facility, marks an important first step in providing governments and public health leaders with the information they need to put in place practical steps for the provision of early doses and a successful national roll-out of vaccines.
The Finance Minister who last week said they had put aside $100 million to purchase the vaccine to achieve herd immunity yesterday said private citizens will have to pay for the vaccine. Zimbabwe will need to vaccinate around 10 million people to achieve herd immunity.